Showing results (31-40 of 124) with videos related to
Sort By:
Pageof 13
Journal of Neurology|May 15, 2022
The timed 25-foot walk is a more sensitive outcome measure than the EDSS for PPMS trials: an analysis of the PROMISE clinical trial datasetMarcus W Koch, Jop Mostert, Pavle Repovic, et al.Multiple Sclerosis Journal - Experimental, Translational and Clinical|August 10, 2018
Objective and subjective measures of dalfampridine efficacy in clinical practiceSylvia Klineova, Rebecca Farber, Joshua Friedman, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|July 25, 2022
The MSIS-29 and SF-36 as outcomes in secondary progressive MS trialsEva Mm Strijbis, Pavle Repovic, Jop Mostert, et al.European Journal of Neurology|June 12, 2023
Threshold definitions for significant change on the timed 25-foot walk and nine-hole peg test in primary progressive multiple sclerosisMarcus W Koch, Pavle Repovic, Jop Mostert, et al.Multiple Sclerosis and Related Disorders|December 3, 2022
The nine hole peg test as an outcome measure in progressive MS trialsMarcus W Koch, Pavle Repovic, Jop Mostert, et al.Neurology and Therapy|November 23, 2020
Effectiveness of Dimethyl Fumarate in Patients With Relapsing Multiple Sclerosis Switching After Suboptimal Response to Glatiramer Acetate, Including Patients With Early Multiple Sclerosis: Subgroup Analysis of RESPONDPavle Repovic, Derrick Robertson, Kiren Kresa-Reahl, et al.Brain : a Journal of Neurology|February 1, 2015
Differential diagnosis of Mendelian and mitochondrial disorders in patients with suspected multiple sclerosisJames D Weisfeld-Adams, Ilana B Katz Sand, Justin M Honce, et al.Multiple Sclerosis and Related Disorders|April 21, 2015
Natalizumab reduces relapse clinical severity and improves relapse recovery in MSFred D Lublin, Gary Cutter, Gavin Giovannoni, et al.Neurology|May 31, 2020
The 2013 clinical course descriptors for multiple sclerosis: A clarificationFred D Lublin, Timothy Coetzee, Jeffrey A Cohen, et al.Journal of Neurology, Neurosurgery, and Psychiatry|October 10, 2025
Extended window of relapse recovery in RRMS: an analysis of the DECIDE datasetJop Mostert, Eva M Strijbis, Miguel D'Haeseleer, et al.Pageof 13